Comparison of template-matching and singular-spectrum-analysis methods for imaging implanted brachytherapy seeds

Brachytherapy using small implanted radioactive seeds is becoming an increasingly popular method for treating prostate cancer, in which a radiation oncologist implants seeds in the prostate transperineally under ultrasound guidance. Dosimetry software determines the optimal placement of seeds for achieving the prescribed dose based on ultrasonic determination of the gland boundaries. However, because of prostate movement and distortion during the implantation procedure, some seeds may not be placed in the desired locations; this causes the delivered dose to differ from the prescribed dose. Current ultrasonic imaging methods generally cannot depict the implanted seeds accurately. We are investigating new ultrasonic imaging methods that show promise for enhancing the visibility of seeds and thereby enabling real-time detection and correction of seed-placement errors during the implantation procedure. Real-time correction of seed-placement errors will improve the therapeutic radiation dose delivered to target tissues. In this work, we compare the potential performance of a template-matching method and a previously published method based on singular spectrum analysis for imaging seeds. In particular, we evaluated how changes in seed angle and position relative to the ultrasound beam affect seed detection. The conclusion of the present study is that singular spectrum analysis has better sensitivity but template matching is more resistant to false positives; both perform well enough to make seed detection clinically feasible over a relevant range of angles and positions. Combining the information provided by the two methods may further reduce ambiguities in determining where seeds are located.

[1]  B W Corn,et al.  Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study. , 1997, International journal of radiation oncology, biology, physics.

[2]  P. Roberson,et al.  Source placement error for permanent implant of the prostate. , 1997, Medical physics.

[3]  N. Yue,et al.  Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. , 1998, International Journal of Radiation Oncology, Biology, Physics.

[4]  R. Stock,et al.  A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.

[5]  P L Roberson,et al.  Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.

[6]  Jonathan Mamou,et al.  Angle-dependent ultrasonic detection and imaging of brachytherapy seeds using singular spectrum analysis. , 2008, The Journal of the Acoustical Society of America.

[7]  G. P. King,et al.  Extracting qualitative dynamics from experimental data , 1986 .

[8]  W. C. de Albuquerque Pereira,et al.  Performance of ultrasound echo decomposition using singular spectrum analysis. , 2001, Ultrasound in medicine & biology.

[9]  H. Holm,et al.  Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. , 1983, The Journal of urology.

[10]  S. L. Bridal,et al.  Singular spectrum analysis applied to backscattered ultrasound signals from in vitro human cancellous bone specimens , 2004, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[11]  C. Clifton Ling,et al.  Determining source strength and source distribution for a transperineal prostate implant , 1996 .

[12]  F M Waterman,et al.  Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants. , 1996, International journal of radiation oncology, biology, physics.

[13]  Jonathan Mamou,et al.  Singular spectrum analysis applied to ultrasonic detection and imaging of brachytherapy seeds. , 2007, The Journal of the Acoustical Society of America.

[14]  J Roy,et al.  Short-term morbidity from CT-planned transperineal I-125 prostate implants. , 1993, International journal of radiation oncology, biology, physics.

[15]  K. Wallner,et al.  CT-based dosimetry for transperineal I-125 prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.

[16]  Ernest J. Feleppa,et al.  Novel methods of analyzing radio-frequency echo signals for the purpose of imaging brachytherapy seeds used to treat prostate cancer , 2002, SPIE Medical Imaging.

[17]  J Roy,et al.  Treatment-related symptoms during the first year following transperineal 125I prostate implantation. , 1994, International journal of radiation oncology, biology, physics.

[18]  J J Prete,et al.  Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[19]  S Nag,et al.  Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.

[20]  L. Potters,et al.  A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. , 2001, International journal of radiation oncology, biology, physics.

[21]  H. Hricak,et al.  Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. , 1996, International journal of radiation oncology, biology, physics.